| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/05/1997 | EP0759943A1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof |
| 03/05/1997 | EP0759942A1 Interleukin-15 receptors |
| 03/05/1997 | EP0759941A1 Heterodimer polypeptide immunogen carrier composition and method |
| 03/05/1997 | EP0759940A1 A dna molecule encoding a mast cell function-associated antigen (mafa) |
| 03/05/1997 | EP0759939A1 Methods and compositions for the dry powder formulation of interferons |
| 03/05/1997 | EP0759938A1 Neurogenic differentiation (neurod) genes and proteins |
| 03/05/1997 | EP0759937A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus |
| 03/05/1997 | EP0759936A1 Vectors with multiple hiv-1 tar sequences inhibiting hiv-1 gene expression |
| 03/05/1997 | EP0759935A1 Recombinant papilloma virus l1 |
| 03/05/1997 | EP0759934A1 Neurotensin antagonist peptides |
| 03/05/1997 | EP0759933A1 Beta sheet forming peptides and gels made thereof |
| 03/05/1997 | EP0759932A1 Collagen from cell cultures |
| 03/05/1997 | EP0759930A1 Chimeric mhc class i antigens for inducing allograft tolerance |
| 03/05/1997 | EP0759786A1 Somatostatin binding peptide-metal chelate conjugates |
| 03/05/1997 | EP0759782A1 New methods and compounds for the selective modulation of antigen-specific t-cell responsiveness |
| 03/05/1997 | EP0759781A1 Method for treating and preventing atherosclerosis |
| 03/05/1997 | EP0759778A1 Non-infective vaccines |
| 03/05/1997 | EP0759777A1 VACCINE FOR $i(MORAXELLA CATARRHALIS) |
| 03/05/1997 | EP0759774A1 Method of treating gram-negative bacterial infection by administration of bactericidal/permeability-increasing (bpi) protein product and antibiotic |
| 03/05/1997 | EP0759772A1 Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent |
| 03/05/1997 | EP0759771A1 Identification of self and non-self antigens implicated in autoimmune disease |
| 03/05/1997 | EP0759770A1 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels |
| 03/05/1997 | EP0759769A1 Peptides and compounds that bind selectins including endothelium leukocyte adhesion molecule 1 (elam-1) |
| 03/05/1997 | EP0759767A1 Covalent dimers of kit ligand and flt-3/flk-2 ligand |
| 03/05/1997 | EP0759762A1 Recombinant fibrin chains, fibrin and fibrin-homologs |
| 03/05/1997 | EP0759759A1 P75 tnf receptor promoters |
| 03/05/1997 | EP0759693A1 METHODS FOR THE IDENTIFICATION OF COMPOUNDS CAPABLE OF ABROGATING HIV-1 Vpr-rip-1 BINDING INTERACTIONS |
| 03/05/1997 | EP0708877B1 Method for repairing a combustion chamber assembly |
| 03/05/1997 | EP0656064B1 Bispecific immunoadhesins |
| 03/05/1997 | EP0612349B1 Novel thrombin inhibitor protein from reduvii |
| 03/05/1997 | EP0597851B1 Method for preparing interferon alpha-2 crystals |
| 03/05/1997 | EP0586545B1 Electrophoretic display panel with tapered grid insulators and associated methods |
| 03/05/1997 | EP0585300B1 Galanin antagonist |
| 03/05/1997 | EP0512087B1 Process for reactivating denatured protein |
| 03/05/1997 | EP0498804B1 A method of preparing a vaccine or toxoid |
| 03/05/1997 | CN1144539A Production of fibrinogen in transgenic animals |
| 03/05/1997 | CN1144536A Novel mutated viruses, anti-viral compounds and novel methods of making vaccines |
| 03/05/1997 | CN1144488A Novel remedy for respiratory-tract viral disease |
| 03/05/1997 | CN1144486A Treatment of ovarian estrogen dependent conditions |
| 03/05/1997 | CN1144271A Acarbose biosynthesis genes from actinoplanes SP., process for isolation thereof and the use thereof |
| 03/05/1997 | CN1034183C Acylamino acid racemase and its producing method and its use |
| 03/04/1997 | US5608152 Seed-specific transcriptional regulation |
| 03/04/1997 | US5608151 Anti-microbial proteins |
| 03/04/1997 | US5608146 DNA sequences with oligosaccharide transporter, plasmids, bacteria and plants containing a transporter as well as a process for the preparation and transformation of yeast strains for identification of the transporter |
| 03/04/1997 | US5608145 High-affinity potassium uptake transporter from higher plants |
| 03/04/1997 | US5608143 External regulation of gene expression |
| 03/04/1997 | US5608142 Genetic engineering |
| 03/04/1997 | US5608039 Single chain B3 antibody fusion proteins and their uses |
| 03/04/1997 | US5608037 Genetic engineering and proteins |
| 03/04/1997 | US5608036 Enhanced secretion of polypeptides |
| 03/04/1997 | US5608035 Peptides and compounds that bind to the IL-1 receptor |
| 03/04/1997 | US5607920 Pharmaceutical and diagnostic aid with cmp; isolation of cmp by isolating chondrocytes, separating membrane proteins therefrom, isolating concanavalin a-binding glycoproteins with concanavalin a-affinity column, isolating cmp |
| 03/04/1997 | US5607919 Anti-microbial proteins |
| 03/04/1997 | US5607918 Vascular endothelial growth factor-B and DNA coding therefor |
| 03/04/1997 | US5607916 Method and composition for the treatment of septic shock |
| 03/04/1997 | US5607915 Pulmonary delivery of active fragments of parathyroid hormone |
| 03/04/1997 | US5607914 Polypeptides for fungicides on plants |
| 03/04/1997 | US5607862 Assay for N-terminal type I collagen telopeptide that survives bone resorption in vivo |
| 03/04/1997 | US5607858 Pentapeptides or hexapeptide amides for diagnosis and anticoagulants |
| 03/04/1997 | US5607846 Vaccine for moraxella catarrhalis |
| 03/04/1997 | US5607845 Method for obtaining an increased production of a producing cell line by using a fusion protocol |
| 03/04/1997 | US5607844 Mammalian augmenter of liver regeneration and variants thereof |
| 03/04/1997 | US5607843 Dna for gene expression and proteins in cells |
| 03/04/1997 | US5607841 Preparation and proteolytic degradation of a macromolecular protein complex from fibrinogen |
| 03/04/1997 | US5607840 Protein hydrolysate derived from mucosa tissue |
| 03/04/1997 | US5607836 Methods of detecting compounds which bind to the P2U receptor |
| 03/04/1997 | US5607676 Immunogenic compositions against gastrin peptides |
| 03/04/1997 | CA2129824C Mutant interleukin 6 with improved biological activity over wild interleukin 6 |
| 03/04/1997 | CA2067797C Production and use of human nm23 protein and antibodies therefor |
| 03/04/1997 | CA2058971C Efficient method for identifiable expression of non-selectable genes |
| 03/04/1997 | CA2013525C Chromogenic dibenzoxazepinone enzyme substrates |
| 03/01/1997 | CA2184334A1 Anticoagulant factor va derivatives |
| 03/01/1997 | CA2184301A1 Bacillus thuringiensis sporulation gene |
| 02/27/1997 | WO1997007404A1 Methods of assessing mhc class i expression and proteins capable of modulating class i expression |
| 02/27/1997 | WO1997007399A1 Method for identifying sex specific and species specific molecules, molecules identified using the method, and uses of the molecules |
| 02/27/1997 | WO1997007387A2 A method and kit for evaluating the metastatic tendency of tumors |
| 02/27/1997 | WO1997007334A1 Axial flow valve system for linear compressor |
| 02/27/1997 | WO1997007233A1 Regulation of cellular functions by ectopic expression of non-endogenous cell signalling receptors |
| 02/27/1997 | WO1997007232A1 Antigenic preparations |
| 02/27/1997 | WO1997007225A2 High efficiency retroviral packaging system |
| 02/27/1997 | WO1997007224A1 Reagents and methods useful for controlling the translation of hepatitis gbv proteins |
| 02/27/1997 | WO1997007219A2 Genes and proteins controlling cholesterol synthesis |
| 02/27/1997 | WO1997007218A1 Allergen-xcd32 fusion proteins |
| 02/27/1997 | WO1997007217A1 Methods and materials for producing pathogen-resistant plants |
| 02/27/1997 | WO1997007216A1 Deuteriated substances |
| 02/27/1997 | WO1997007215A1 Agonists of haemopoietic growth factors |
| 02/27/1997 | WO1997007214A1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology |
| 02/27/1997 | WO1997007213A2 Assay for identifying genes causing chromosome non-disjunction |
| 02/27/1997 | WO1997007212A1 Opioid antagonists and methods of their use |
| 02/27/1997 | WO1997007211A1 Materials and methods for detection and treatment of insulin-dependent diabetes |
| 02/27/1997 | WO1997007210A1 Recombinant conglutinin and process for producing the same |
| 02/27/1997 | WO1997007209A2 Receptor |
| 02/27/1997 | WO1997007208A1 Nucleic acid molecules encoding peptides having pronociceptive properties |
| 02/27/1997 | WO1997007198A2 Dna sequences and secreted proteins encoded thereby |
| 02/27/1997 | WO1997007135A2 Binding of osteogenic protein-i (op-1) and analogs thereof to the cell surface receptor alk-1 and analogs thereof |
| 02/27/1997 | WO1997007134A1 Traf inhibitors |
| 02/27/1997 | WO1997007133A1 Recombinant conglutinin and process for producing the same |
| 02/27/1997 | WO1997007132A1 Epitope tagging system |
| 02/27/1997 | WO1997007128A1 A method to increase the density of antigen on antigen presenting cells |
| 02/27/1997 | WO1997007127A1 Dna encoding suppressin protein and uses thereof |